Table 1: Characteristics of participants in
a cervical cancer screening event in the locomapa
region, honduras.
Participants’ Characteristicsa |
Overall N = 449 |
Prior Pap N = 316 |
No Prior Pap N = 133 |
HPV Positive N = 71 |
HPV 16/18 N = 15 |
|
N (column %) |
||||
Sociodemographic |
|||||
Age category (years) |
|||||
< 21 |
20 (4.5) |
6 (1.9) |
14 (10.5) |
4 (5.6) |
0 (0.0) |
21-25 |
45 (10.0) |
15 (4.8) |
30 (22.6) |
6 (8.5) |
2 (13.3) |
26-30 |
58 (12.9) |
29 (9.2) |
29 (21.8) |
12 (16.9) |
3 (20.0) |
31-35 |
71 (15.8) |
54 (17.1) |
17 (12.8) |
8 (11.3) |
2 (13.3) |
36-40 |
54 (12.0) |
36 (11.4) |
18 (13.5) |
10 (14.1) |
2 (13.3) |
41-45 |
40 (8.9) |
36 (11.4) |
4 (3.0) |
2 (2.8) |
0 (0.0) |
46-50 |
41 (9.1) |
34 (10.7) |
7 (5.3) |
10 (14.1) |
3 (20.0) |
> 50 |
120 (26.7) |
106 (33.5) |
14 (10.5) |
19 (26.8) |
3 (20.0) |
Years of dducation |
|||||
None |
72 (16.6) |
39 (12.8) |
33 (25.4) |
15 (22.7) |
3 (23.1) |
1-3 |
76 (17.5) |
54 (17.8) |
22 (16.9) |
12 (18.2) |
2 (15.4) |
4-6 |
240 (55.3) |
182 (59.9) |
58 (44.6) |
29 (43.9) |
6 (46.2) |
7-9 |
22 (5.1) |
16 (5.3) |
6 (4.6) |
4 (6.1) |
0 (0.0) |
> 9 |
24 (5.5) |
13 (4.3) |
11 (8.5) |
6 (9.1) |
2 (15.4) |
% of Life residing in locomapa region |
|||||
100 |
129 (31.7) |
91 (31.5) |
38 (32.2) |
18 (27.3) |
7 (63.6) |
50- < 100 |
110 (27.0) |
90 (31.1) |
20 (17.0) |
18 (27.3) |
3 (27.3) |
< 50 |
168 (41.3) |
108 (37.4) |
60 (50.8) |
30 (45.5) |
1 (9.1) |
Personal and Family History |
|||||
Age at first menstrual period
(yrs.) |
|||||
< 13 |
76 (17.0) |
53 (16.8) |
23 (17.3) |
11 (15.7) |
4 (23.7) |
13-14 |
235 (52.5) |
162 (51.4) |
73 (54.9) |
38 (54.3) |
8 (53.3) |
> 14 |
137 (30.6) |
100 (31.8) |
37 (27.8) |
21 (30.0) |
3 (20.0) |
Number of children |
|||||
None |
7 (1.6) |
3 (1.0) |
4 (3.0) |
3 (4.2) |
1 (6.7) |
1-2 |
124 (27.6) |
73 (23.1) |
51 (38.4) |
20 (28.2) |
4 (26.7) |
3-4 |
132 (29.4) |
105 (33.2) |
27 (20.3) |
20 (28.2) |
2 (13.3) |
5-8 |
136 (30.3) |
101 (32.0) |
35 (26.3) |
18 (25.4) |
6 (40.0) |
> 8 |
50 (11.1) |
34 (10.8) |
16 (12.0) |
10 (14.1) |
2 (13.3) |
Age at birth of first child (yrs.) |
|||||
< 18 |
172 (39.1) |
105 (33.7) |
67 (52.3) |
29 (43.3) |
9 (64.3) |
18-20 |
157 (35.7) |
118 (37.8) |
39 (30.5) |
18 (26.9) |
0 (0.0) |
21-25 |
87 (19.8) |
69 (22.1) |
18 (14.1) |
14 (20.9) |
3 (21.4) |
> 25 |
24 (5.5) |
20 (6.4) |
4 (3.1) |
6 (9.0) |
2 (14.3) |
Number of sexual partners
(cumulative) |
|||||
1 |
256 (57.0) |
181 (57.3) |
75 (56.4) |
35 (49.3) |
12 (80.0) |
2 |
180 (40.1) |
123 (38.9) |
57 (42.9) |
31 (43.7) |
2 (13.3) |
3-5 |
13 (2.9) |
12 (3.8) |
1 (1.0) |
5 (7.0) |
1 (6.7) |
Regularly use family planning
method |
|||||
Oral
contraceptives |
119 (26.5) |
93 (33.0) |
26 (20.2) |
19 (28.8) |
7 (50.0) |
Condom |
1 (< 1) |
1 (< 1) |
0 (0.0) |
1 (1.5) |
0 (0.0) |
Other |
98 (21.8) |
69 (24.5) |
47 (36.4) |
12 (18.2) |
1 (7.1) |
None |
193 (47.0) |
137 (48.6) |
56 (43.4) |
34 (51.5) |
6 (42.9) |
Family history of cervical cancer
with first degree relative |
|||||
None |
417 (95.4) |
289 (94.4) |
128 (97.7) |
67 (95.7) |
14 (93.3) |
One or more |
20 (4.6) |
17 (5.6) |
3 (2.3) |
3 (4.3) |
1 (6.7) |
Knowledge and perceptions |
|||||
Had heard about cervical cancer
screening tests before Jornada |
|||||
Yes - Pap test |
336 (74.8) |
271 (85.8) |
65 (48.9) |
54 (76.1) |
10 (66.7) |
Yes - doctor
inspects cervix |
39 (8.7) |
29 (9.2) |
10 (7.5) |
5 (7.0) |
10 (6.67) |
Yes - Pap test
and doctor inspects cervix |
2 (< 1) |
1 (< 1) |
1 (1.5) |
0 (0.0) |
0 (0.0) |
No |
72 (16.0) |
15 (4.8) |
57 (42.9) |
12 (16.9) |
4 (26.7) |
Had heard about human
papillomavirus before Jornada |
|||||
Yes - Heard that HPV can cause cervical cancer |
183 (41.3) |
138 (44.1) |
45 (34.6) |
34 (48.6) |
6 (40.0) |
Yes - Had NOT heard that HPV can cause cervical
cancer |
49 (11.1) |
38 (12.1) |
11 (8.5) |
7 (10.0) |
3 (20.0) |
No |
211 (47.6) |
137 (43.8) |
74 (56.9) |
29 (41.4) |
6 (40.0) |
If given opportunity, would want
to get HPV vaccine |
|||||
Yes |
398 (90.1) |
280 (89.7) |
118 (90.8) |
61 (87.1) |
3 (20.0) |
No |
44 (9.9) |
32 (10.3) |
12 (9.2) |
9 (12.9) |
12 (80.0) |
If given opportunity, would you
want daughter(s) to get HPV vaccine |
|||||
Yes |
398 (89.8) |
280 (90.0) |
118 (89.4) |
63 (88.7) |
3 (20.0) |
No |
45 (10.2) |
31 (10.0) |
14 (10.6) |
8 (11.3) |
12 (80.0) |
Access |
|
|
|
|
|
How they heard about the Jornadab |
|||||
Community
leader |
291 (64.8) |
201 (63.6) |
90 (67.7) |
43 (60.6) |
10 (66.7) |
Radio |
28 (6.2) |
23 (7.3) |
5 (3.8) |
2 (2.8) |
0 (0.0) |
Television |
2 (< 1) |
2 (< 1) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Told by
family/friends |
131 (29.2) |
97 (30.7) |
34 (25.6) |
27 (38.0) |
5 (33.3) |
Other |
19 (4.2) |
14 (4.4) |
5 (3.8) |
0 (0.0) |
0 (0.0) |
Mode of transportation to
screening event |
|||||
Bus provided for
event |
166 (37.1) |
111 (35.2) |
55 (41.4) |
30 (42.3) |
8 (53.3) |
Public bus |
5 (1.1) |
3 (1.0) |
2 (1.5) |
1 (1.4) |
0 (0.0) |
Car/Truck |
22 (4.9) |
21 (6.7) |
1 (1.0) |
7 (9.9) |
2 (13.3) |
Walked |
246 (54.9) |
172 (54.6) |
74 (55.6) |
32 (45.1) |
5 (33.3) |
Horse/Cart |
4 (1.0) |
4 (1.3) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Other |
5 (1.1) |
4 (1.3) |
1 (1.0) |
1 (1.4) |
0 (0.0) |
Mode of transportation most likely
to use when seeking healthcare |
|||||
Bus |
160 (35.9) |
106 (33.8) |
54 (40.9) |
28 (39.4) |
6 (40.0) |
Car/Truck |
5 (1.1) |
5 (1.6) |
0 (0.0) |
2 (2.8) |
1 (6.7) |
Walking |
277 (62.1) |
199 (63.4) |
78 (59.1) |
41 (57.8) |
8 (53.3) |
Horse/Cart |
1 (< 1) |
1 (< 1) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Other |
3 (1.0) |
3 (1.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Time to nearest Pap test location |
|||||
≤ 30 min. |
156 (34.8) |
125 (39.6) |
31 (23.5) |
25 (35.2) |
5 (33.3) |
> 30 min. - 1 hour |
75 (16.7) |
50 (15.8) |
25 (18.9) |
11 (15.5) |
2 (13.3) |
> 1-2 hours |
131 (29.2) |
91 (28.8) |
40 (30.3) |
24 (33.8) |
5 (33.3) |
> 2 hours |
86 (19.2) |
50 (15.8) |
36 (27.3) |
11 (15.5) |
3 (20.0) |
aMissing (N): Education (15), % of Life
residing in Locomapa region (42), Age at first
menstrual period (1), Number of children (7),
Age at first birth (9), Regular use of family planning method (38),
Family history of cervical cancer (12), Heard of cervical cancer screening test
with prior Pap test (67), Heard of HPV before Jornada
(6), If given opportunity, would want to get HPV vaccine (7), If given
opportunity, would you want daughter(s) to get HPV vaccine (6), Mode of
transportation to screening event(1), Mode of transportation most likely to use
when seeking healthcare (3), Time to nearest Pap test location (1).
bNot mutually exclusive